Ben Arye Barak - Feb 28, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: General Counsel
Signature: By: /s/ Steven Robbins, Attorney in Fact for Barak Ben Arye
Stock symbol: NVCR
Transactions as of: Feb 28, 2023
Transactions value $: $2,273,001
Form type: 4
Date filed: 3/2/2023, 03:56 PM
Previous filing: Jan 10, 2023
Next filing: Jul 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$0	+17.8K	+103.52%	$0.00	34.9K	Feb 28, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$2.27M	+29.5K		$76.97	29.5K	Feb 28, 2023	Ordinary Shares	29.5K	$76.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F2	Options to buy 29,531 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.